Skip to main content
. 2020 Nov 9;5(2):113–121. doi: 10.1016/S2352-4642(20)30342-4

Table 3.

Treatment and outcomes

Cases (n=66)
Highest location of care
Neonatal unit 20 (30%)
Paediatric intensive care unit 4 (6%)
Paediatric inpatient ward 30 (45%)
Postnatal ward 12 (18%)
Clinical care received for COVID-19
Invasive ventilation (endotracheal intubation)* 3 (5%)
Non-invasive ventilation* 10 (15%)
Supplemental oxygen* 22 (33%)
High-frequency oscillatory ventilation 0
Nitric oxide 0
Extracorporeal membrane oxygenation 0
No respiratory support 42 (64%)
Therapeutic hypothermia 0
Missing data 2 (3%)
Treatments received at time of COVID-19
Antibiotics 46 (70%)
Antivirals 2 (3%)
Corticosteroids 2 (3%)
Anti-arrhythmic treatment 1 (2%)
Immunoglobulin 1 (2%)
Outcome
Still admitted 3 (5%)
Discharged home 58 (88%)
With home oxygen 0
With home respiratory support 0
For palliative care 0
With community nursing 2 (3%)
No additional support 56 (85%)
Transferred to another hospital 4 (6%)
Died 1 (2%)
Missing data 0

Data are n (%).

*

Some babies received multiple forms of respiratory support.

Administered for condition considered unrelated to COVID-19.